Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
BY WEIGHT
15
# OF OVERLAPPING HOLDINGS
MDEV
55
HOLDINGS
30%
ALSO IN FMED
FMED
62
HOLDINGS
27%
ALSO IN MDEV
SECTOR DRIFT (MDEV minus FMED)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MDEV |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
INSULET CORP | 2.3% | 4.3% | 2.3% |
|
EXACT SCIENCES CORP | 2.2% | 2.6% | 2.2% |
|
DEXCOM INC | 2.3% | 2.1% | 2.1% |
|
BOSTON SCIENTIFIC CORP | 2.1% | 7.3% | 2.1% |
|
EDWARDS LIFESCIENCES CORP | 2.1% | 2.2% | 2.1% |
MDEV Overweight Relative to FMED
 |
WUXI APPTEC CO., LTD. CLASS H | 2.7% |
 |
WILLIAM DEMANT HOLDING A/S | 2.3% |
 |
HOYA CORP | 2.3% |
 |
SMITH & NEPHEW PLC | 2.2% |
 |
COCHLEAR LIMITED | 2.2% |
|
GE HEALTHCARE TECHNOLOGIES INC. | 2.2% |
|
AGILENT TECHNOLOGIES INC | 2.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.1% |
 |
AMPLIFON SPA | 2.1% |
 |
SIEMENS HEALTHINEERS AG | 2.1% |
MDEV Underweight Relative to FMED
|
BOSTON SCIENTIFIC CORP | -5.2% |
|
UNITEDHEALTH GROUP INC | -4.0% |
 |
ARGENX SE ADR | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.0% |
|
UCB SA | -2.8% |
|
AGILON HEALTH INC | -2.8% |
|
ALNYLAM PHARMACEUTICALS INC | -2.8% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.5% |
|
INTUITIVE SURGICAL INC | -2.5% |